Filtering by: Department Biotechnology Remove constraint Department: Biotechnology Subject communication Remove constraint Subject: communication
ProjectEvaluating Communication Channels and Practices Within and Across the Ardea Phase 3 Clinical ProgramTruong, KathyArdea Biosciences, Inc., a wholly owned subsidiary of AstraZeneca, PLC., recently developed several gout drugs, with Lesinurad as the most advanced product candidate in Phase 3 clinical trials. A new organizational structure was implemented for execut . . .